TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest update is out from Japan Animal Referral Medical Center Co., Ltd. ( (JP:6039) ).
Japan Animal Referral Medical Center Co., Ltd. reported a significant increase in its consolidated financial results for the six months ended September 30, 2025, with net sales rising by 18.1% and operating profit increasing by 68.4% compared to the previous year. The company also forecasts continued growth for the full fiscal year ending March 31, 2026, indicating strong operational performance and a positive outlook for stakeholders.
The most recent analyst rating on (JP:6039) stock is a Buy with a Yen4478.00 price target. To see the full list of analyst forecasts on Japan Animal Referral Medical Center Co., Ltd. stock, see the JP:6039 Stock Forecast page.
More about Japan Animal Referral Medical Center Co., Ltd.
Japan Animal Referral Medical Center Co., Ltd. (JARMeC) operates in the veterinary medical services industry, focusing on providing specialized medical care for animals. The company is listed on the Tokyo Stock Exchange and is known for its advanced referral medical services.
Average Trading Volume: 38,098
Technical Sentiment Signal: Buy
Current Market Cap: Yen13.65B
Find detailed analytics on 6039 stock on TipRanks’ Stock Analysis page.